INJEKTIONSVORRICHTUNG

European patent · EP3836994 · In force

Register entry

Publication number
EP3836994
Application number
EP19752209
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 13, 2019
Published
Jun 23, 2021
Granted
Feb 19, 2025
Protection ends at the latest
Aug 12, 2039
Next annual fee due
Aug 31, 2027
IPC classes
A61M 5/32 (2006.01)
A61M 5/24 (2006.01)
Priority
EP 18306113 13.08.2018
PCT application
PCT/EP2019/071768 13.08.2019
PCT publication
WO2020/035513 20.02.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Dec 31, 2025

    Change

    Published in Swissreg on 31.12.2025

  3. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  4. Feb 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.02.2025

Parties

Holder

SANOFI

Sanofi

54, rue La Boétie, 75008 Paris, FR

Inventor

DASBACH, Uwe

65926 Frankfurt am Main, DE

KEMP, Thomas

Melbourn Herts, Cambridgeshire SG8 6DP, GB

REVELLAT, Hugo

Melbourn Herts, Cambridgeshire SG8 6DP, GB

BRADFORD, Jim

Melbourn Herts, Cambridgeshire SG8 6DP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.